These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20954795)

  • 1. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
    Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
    J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
    Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
    Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat.
    Varshosaz J; Ahmadi F; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    J Microencapsul; 2011; 28(1):62-73. PubMed ID: 21171817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat.
    Varshosaz J; Ahmadi F; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Int J Prev Med; 2010; 1(2):115-23. PubMed ID: 21566772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Albizia procera gum as compression coating material for colonic delivery of budesonide.
    Pachuau L; Mazumder B
    Int J Biol Macromol; 2013 Oct; 61():333-9. PubMed ID: 23916644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation.
    Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Rahmani N; Dorkoosh F; Mahzouni P
    Acta Pharm; 2012 Nov; 62(3):341-56. PubMed ID: 23470347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA; Elshafeey AH; Sayed I; Shehata AH
    AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice.
    Gareb B; Dijkstra G; Kosterink JGW; Frijlink HW
    Int J Pharm; 2019 Jan; 554():366-375. PubMed ID: 30414898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
    Patel NV; Patel JK; Shah SH; Patel JN
    Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
    Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
    Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.
    Nour SA; Abdelmalak NS; Naguib MJ
    Drug Deliv; 2015 May; 22(3):286-97. PubMed ID: 24601826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.
    Jagdale S; Chandekar A
    Recent Pat Antiinfect Drug Discov; 2016; 11(1):32-43. PubMed ID: 26377799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats.
    Rodriguez M; Antúnez JA; Taboada C; Seijo B; Torres D
    J Pharm Pharmacol; 2001 Sep; 53(9):1207-15. PubMed ID: 11578103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
    D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
    J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
    Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
    Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis.
    Bezzio C; Festa S; Zerboni G; Papi C; Manes G; Saibeni S
    Expert Opin Drug Saf; 2018 Apr; 17(4):437-444. PubMed ID: 29473429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.